Fulgent Genetics (FLGT) vs Precipio (PRPO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Precipio (PRPO) has outperformed Fulgent Genetics (FLGT) over the past year, gaining 17.6% versus a loss of 4.2%. Over five years, PRPO leads with a -54.8% price change compared with -72.1% for FLGT. Fulgent Genetics is the larger company by market cap ($598.2 million vs $41.4 million), about 14.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FLGT | PRPO |
|---|---|---|
| Share price | $21.74 | $23.12 |
| Market cap | $598.18M | $41.39M |
| 1-day change | +4.42% | -0.30% |
| YTD return | -17.24% | +0.61% |
| 1-year return | -4.19% | +17.60% |
| 5-year return | -72.14% | -54.84% |
| Forward P/E | — | 59.28 |
| EPS (TTM) | $-2.82 | $-0.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $31.04 | $33.63 |
| 52-week low | $13.46 | $16.40 |
| Distance from 52-week high | -29.96% | -31.25% |
| Analyst consensus | none | — |
| Avg. price target upside | -12.60% | — |
| Average volume | 301.70K | 125.71K |
| Shares outstanding | 27.52M | 1.79M |
| Employees | 1,315 | 61 |
| Sector | Health Care | Industrials |
| Industry | Medical Specialities | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Fulgent Genetics is about 14.5 times larger than Precipio by market value ($598.18M vs $41.39M).
- PRPO has outperformed FLGT by 21.8 percentage points over the past year.
- The two companies sit in different sectors: Fulgent Genetics in Health Care and Precipio in Industrials.
About Fulgent Genetics
FLGT stock →Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.
Health Care · Medical Specialities · 1,315 employees
About Precipio
PRPO stock →Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services.
Industrials · Biotechnology: Laboratory Analytical Instruments · 61 employees
FLGT vs PRPO FAQ
Which is bigger, Fulgent Genetics or Precipio?
Fulgent Genetics (FLGT) is larger, with a market capitalization of $598.18M compared with $41.39M for Precipio (PRPO).
Which stock has performed better over the past year, FLGT or PRPO?
PRPO returned +17.60% over the past 12 months, compared with -4.19% for FLGT (price return, excluding dividends). Past performance does not predict future results.
Are Fulgent Genetics and Precipio in the same industry?
No. Fulgent Genetics is in the Health Care sector, while Precipio is in Industrials.